Brain pharmacokinetics of neurotoxin-loaded PLA nanoparticles modified with chitosan after intranasal administration in awake rats

References

• Bickel U, Yoshikawa T, Pardridge WM. (2001). Delivery of peptides and proteins through the blood-brain barrier. Adv Drug Deliv Rev, 46:247–279.
   PubMed Web of Science ®Google Scholar
• Banks WA. (2008). Delivery of peptides to the brain: emphasis on therapeutic development. Biopolymers, 90:589–594.
   PubMed Web of Science ®Google Scholar
• Frey WH II. (2002). Bypassing the blood-brain barrier to delivery therapeutic agents to the brain and spinal cord. Drug Del Tech, 2:46–49.
   Google Scholar
• Dhuria SV, Hanson LR, Frey WH 2nd. (2010). Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci, 99:1654–1673.
   PubMed Web of Science ®Google Scholar
• Wu H, Hu K, Jiang X. (2008). From nose to brain: understanding transport capacity and transport rate of drugs. Expert Opin Drug Deliv, 5:1159–1168.
   PubMed Web of Science ®Google Scholar
• Ali J, Ali M, Baboota S, Sahani JK, Ramassamy C, Dao L et al. (2010). Potential of nanoparticulate drug delivery systems by intranasal administration. Curr Pharm Des, 16:1644–1653.
   PubMed Web of Science ®Google Scholar
• Vaka SR, Sammeta SM, Day LB, Murthy SN. (2009). Delivery of nerve growth factor to brain via intranasal administration and enhancement of brain uptake. J Pharm Sci, 98:3640–3646.
   PubMed Web of Science ®Google Scholar
• Illum L. (2000). Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci, 11:1–18.
   PubMed Web of Science ®Google Scholar
• Dufes C, Olivier JC, Gaillard F, Gaillard A, Couet W, Muller JM. (2003). Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats. Int J Pharm, 255:87–97.
   PubMed Web of Science ®Google Scholar
• Krauland AH, Bernkop-Schnürch A. (2004). Thiomers: development and in vitro evaluation of a peroral microparticulate peptide delivery system. Eur J Pharm Biopharm, 57:181–187.
   PubMed Web of Science ®Google Scholar
• Mistrya A, Stolnika S, Illum L. (2009). NPs for direct nose-to-brain delivery of drugs. Int J Pharm, 379:146–157.
   PubMedGoogle Scholar
• Kumar MNVR. (2000). A review of chitin and chitosan applications. React Funct Polym, 46:1–27.
   Web of Science ®Google Scholar
• Khor E, Lim LY. (2003). Implantable applications of chitin and chitosan. Biomaterials, 24:2339–2349.
   PubMed Web of Science ®Google Scholar
• Llabot JM, Salman H, Millotti G, Bernkop-Schnürch A, Allemandi D, Manuel Irache J. (2011). Bioadhesive properties of poly(anhydride) nanoparticles coated with different molecular weights chitosan. J Microencapsul, 28:455–463.
   PubMed Web of Science ®Google Scholar
• Mangal S, Pawar D, Garg NK, Jain AK, Vyas SP, Rao DS et al. (2011). Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system(s) administered intranasally. Vaccine, 29:4953–4962.
   PubMed Web of Science ®Google Scholar
• Luckachan GE, Pillai CKS. (2006). Chitosan/oligo L-lactide graft copolymers: effect of hydrophobic side chains on the physico-chemical properties and biodegradability. Carbohydrate Polymers, 64:254–266.
   Web of Science ®Google Scholar
• Yuan XB, Li H, Yuan YB. (2006). Preparation of cholesterol-modified chitosan self-aggregated nanoparticles for delivery of drugs to ocular surface. Carbohydrate Polymers, 65:337–345.
   Web of Science ®Google Scholar
• Sheng Y, Liu C, Yuan Y, Tao X, Yang F, Shan X, et al. (2009). Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan. Biomaterials, 30:2340–2348.
   PubMed Web of Science ®Google Scholar
• Tsetlin V. (1999). Snake venom alpha-neurotoxins and other ‘three-finger’ proteins. Eur J Biochem, 264:281–286.
   PubMedGoogle Scholar
• Chung YI, Tae G, Hong Yuk S. (2006). A facile method to prepare heparin-functionalized nanoparticles for controlled release of growth factors. Biomaterials, 27:2621–2626.
   PubMed Web of Science ®Google Scholar
• Vila A, Sánchez A, Tobío M, Calvo P, Alonso MJ. (2002). Design of biodegradable particles for protein delivery. J Control Release, 78:15–24.
   PubMed Web of Science ®Google Scholar
• Bergquist J, Vona MJ, Stiller CO, O’Connor WT, Falkenberg T, Ekman R. (1996). Capillary electrophoresis with laser-induced fluorescence detection: a sensitive method for monitoring extracellular concentrations of amino acids in the periaqueductal grey matter. J Neurosci Methods, 65:33–42.
   PubMed Web of Science ®Google Scholar
• Paxinos G, Watson C. (1997). The Rat Brain in Stereotaxic Coordinates. Sydney: Academic Press.
   Google Scholar
• Bagger MA, Bechgaard E. (2004). The potential of nasal application for delivery to the central brain-a microdialysis study of fluorescein in rats. Eur J Pharm Sci, 21:235–242.
   PubMed Web of Science ®Google Scholar
• Williams FG, Mullet MA, Beitz AJ. (1995). Basal release of Met-enkephalin and neurotensin in the ventrolateral periaqueductal gray matter of the rat: a microdialysis study of antinociceptive circuits. Brain Res, 690:207–216.
   PubMed Web of Science ®Google Scholar
• Trapani A, De Giglio E, Cafagna D, Denora N, Agrimi G, Cassano T et al. (2011). Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery. Int J Pharm, 419:296–307.
   PubMed Web of Science ®Google Scholar
• Tahara K, Miyazaki Y, Kawashima Y, Kreuter J, Yamamoto H. (2011). Brain targeting with surface-modified poly(D,L-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration. Eur J Pharm Biopharm, 77:84–88.
   PubMed Web of Science ®Google Scholar
• Wang ZH, Wang ZY, Sun CS, Wang CY, Jiang TY, Wang SL. (2010). Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain. Biomaterials, 31:908–915.
   PubMed Web of Science ®Google Scholar
• Wang X, Chi N, Tang X. (2008). Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting. Eur J Pharm Biopharm, 70:735–740.
   PubMed Web of Science ®Google Scholar
• Hoekman JD, Ho RJ. (2011). Effects of localized hydrophilic mannitol and hydrophobic nelfinavir administration targeted to olfactory epithelium on brain distribution. AAPS PharmSciTech, 12:534–543.
   PubMed Web of Science ®Google Scholar
• Charlton ST, Whetstone J, Fayinka ST, Read KD, Illum L, Davis SS. (2008). Evaluation of direct transport pathways of glycine receptor antagonists and an angiotensin antagonist from the nasal cavity to the central nervous system in the rat model. Pharm Res, 25:1531–1543.
   PubMed Web of Science ®Google Scholar
• Al-Ghananeem AM, Saeed H, Florence R, Yokel RA, Malkawi AH. (2010). Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by AIDS viruses. J Drug Target, 18:381–388.
   PubMed Web of Science ®Google Scholar
• Li F, Feng J, Cheng Q, Zhu W, Jin Y. (2007). Delivery of 125I-cobrotoxin after intranasal administration to the brain: a microdialysis study in freely moving rats. Int J Pharm, 328:161–167.
   PubMedGoogle Scholar
• Illum L. (2003). Nasal drug delivery–possibilities, problems and solutions. J Control Release, 87:187–198.
   PubMed Web of Science ®Google Scholar
• Kreuter J. (2001). Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev, 47:65–81.
   PubMed Web of Science ®Google Scholar
• Kreuter J, Ramge P, Petrov V, Hamm S, Gelperina SE, Engelhardt B et al. (2003). Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles. Pharm Res, 20:409–416.
   PubMed Web of Science ®Google Scholar
• Kreuter J. (2002). Transport of drugs across the blood-brain barrier by NPs. Curr Med Chem CNS Agents, 9:241–249.
   Google Scholar
• Pan YF, Feng J, Cheng QY, Li FZ. (2007). Intracerebral microdialysis technique and its application on brain pharmacokinetic-pharmacodynamic study. Arch Pharm Res, 30:1635–1645.
   PubMed Web of Science ®Google Scholar
• Hammarlund-Udenaes M. (2000). The use of microdialysis in CNS drug delivery studies. Pharmacokinetic perspectives and results with analgesics and antiepileptics. Adv Drug Deliv Rev, 45:283–294.
   PubMed Web of Science ®Google Scholar
• Hammarlund-Udenaes M. (2010). Active-site concentrations of chemicals - are they a better predictor of effect than plasma/organ/tissue concentrations? Basic Clin Pharmacol Toxicol, 106:215–220.
   PubMed Web of Science ®Google Scholar